reductions in placental (15%; pb0.002) and fetal (54%; p b0.002) weights in RAGE -/-mice compared to SHS-exposed controls. In the fetus, their lung showed increased apoptosis, decreased collagen IV expression (2.5-fold; pb0.05), increased MMP-9 (3-fold; p b0.05), increased TNF-(3.8-fold; p b0.05) and increased IL-1 (7-fold; pb0.05) expression. All of these were profoundly reduced in the RAGE -/-mice compared to SHS-exposed controls. We concluded that SHS-induced IUGR is directly influenced by RAGE and that SHS directly affects fetal lung development in a RAGE dependent manner. These studies provide insight into tobacco-mediated IUGR development and clarify avenues that may be helpful in the alleviation of fetal lung SHS-induced complications. Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders that cause excessive proliferation of specific myeloid lineages. The majority of MPN patients have a point mutation in the JAK2 gene (JAK2V617F) encoding a dominant-active kinase that constitutively triggers JAK/STAT signaling. In Drosophila, the JAK/STAT pathway is conserved but simplified, with a single JAK Hopscotch (Hop) and a single STAT (Stat92E). The hopTum-l allele encodes a dominant-active kinase that hyper-activates Stat92E. Like MPN patients, hopTum-l mutants have dramatically increased myeloid cells (called plasmatocytes and lamellocytes), which aggregate to form lethal melanotic tumors.
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The Tip60/Enhancer of Polycomb (E(Pc)) complex is a tumor suppressor that represses hematopoietic tumors by negatively regulating JAK/STAT signaling Alessandro Bailetti, Abigail Anderson, Lenny Negron-Piñeiro, Vishal Dhruva, Erika Bach
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Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders that cause excessive proliferation of specific myeloid lineages. The majority of MPN patients have a point mutation in the JAK2 gene (JAK2V617F) encoding a dominant-active kinase that constitutively triggers JAK/STAT signaling. In Drosophila, the JAK/STAT pathway is conserved but simplified, with a single JAK Hopscotch (Hop) and a single STAT (Stat92E). The hopTum-l allele encodes a dominant-active kinase that hyper-activates Stat92E. Like MPN patients, hopTum-l mutants have dramatically increased myeloid cells (called plasmatocytes and lamellocytes), which aggregate to form lethal melanotic tumors.
We performed a sensitized deficiency screen to find dominant modifiers of hopTum-l tumors. A deficiency that uncovers Enhancer of Polycomb (E(Pc)) significantly enhanced the melanotic tumor burden in hopTum-l animals, as did heterozygosity for E(Pc) hypomorphic alleles. Moreover, hematopoietic depletion of E(Pc) in an otherwise wild-type background caused precocious differentiation of lamellocytes and melanotic tumors. E(Pc) is a component of the Tip60 Histone Acetyl Transferase complex. In support of the model that E(Pc) functions through the Tip60 complex in blood cells, depletion of Tip60 or other complex components resulted in precocious lamellocyte differentiation and small melanotic tumors.
We next addressed whether the E(Pc) tumor phenotype was dependent on JAK/STAT activity. Indeed, depletion of Stat92E inhibited tumor formation caused by E(Pc) knock down, indicating an epistatic interaction between E(Pc)/Tip60 and Stat92E. Furthermore, we showed that E(Pc) mutant cells have increased expression of Stat92E target genes. These data strongly suggest that E(Pc) represses tumor formation by attenuating JAK/STAT activity, possibly by either direct acetylation of Stat92E or by transcriptional induction of suppressors of Stat92E. Biochemical approaches and whole genome sequencing will be used to distinguish between these possibilities. In sum, we have identified a new regulator of hematopoiesis in Drosophila that may have conserved functions in higher organisms. Here we provide fundamental insights into early human development by single-cell RNA-sequencing of human and mouse preimplantation embryos. We elucidate conserved transcriptional programs along with those that are human-specific. Importantly, we validate our RNA-sequencing findings at the protein level, which further reveals differences in human and mouse embryo gene expression. For example, we identify several genes exclusively expressed in the human pluripotent epiblast including the transcription factor KLF17. Key components of the TGF-β signaling pathway including NODAL, GDF3, TGFBR1/ALK5, LEFTY1, SMAD2, SMAD4 and TDGF1 are also enriched in the human epiblast. Intriguingly, inhibition of TGF-β signaling abrogates NANOG expression in human epiblast cells, consistent with a requirement for this pathway in pluripotency. Although key trophectoderm factors Id2, Elf5, and Eomes are exclusively localized to this lineage in the mouse, the human orthologues are either absent or expressed in alternative lineages. Importantly, we also identify genes with conserved expression dynamics including Foxa2/FOXA2, which we show is restricted to the primitive endoderm in both human and mouse embryos. Comparisons of the human epiblast to existing embryonic stem cells (hESCs) reveals conservation of pluripotency but also additional pathways more enriched in hESCs. Our analysis highlights significant differences in human preimplantation development compared to mouse and provides a molecular blueprint to understand human embryogenesis and its relationship to stem cells. doi:10.1016/j.mod.2017.04.015 PS1.9 UGDH germline loss-of-function mutations cause epilepsy and global developmental delay Célia Bosso-Lefèvre a , Emily Yu
